Graham T. Wehmeyer

2.7k total citations
7 papers, 77 citations indexed

About

Graham T. Wehmeyer is a scholar working on Oncology, Critical Care and Intensive Care Medicine and Epidemiology. According to data from OpenAlex, Graham T. Wehmeyer has authored 7 papers receiving a total of 77 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Critical Care and Intensive Care Medicine and 2 papers in Epidemiology. Recurrent topics in Graham T. Wehmeyer's work include Pneumonia and Respiratory Infections (2 papers), Intensive Care Unit Cognitive Disorders (2 papers) and COVID-19 and healthcare impacts (2 papers). Graham T. Wehmeyer is often cited by papers focused on Pneumonia and Respiratory Infections (2 papers), Intensive Care Unit Cognitive Disorders (2 papers) and COVID-19 and healthcare impacts (2 papers). Graham T. Wehmeyer collaborates with scholars based in United States. Graham T. Wehmeyer's co-authors include Han A. Li, Mark N. Alshak, Scott Lovell, K.P. Battaile, Justin J. Choi, Susan M. Egan, Mangala Rajan, Parag Goyal, Monika M. Safford and Laura C. Pinheiro and has published in prestigious journals such as Blood, Journal of General Internal Medicine and Academic Medicine.

In The Last Decade

Graham T. Wehmeyer

7 papers receiving 74 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Graham T. Wehmeyer United States 6 22 19 12 11 10 7 77
Monica Brackney United States 6 14 0.6× 26 1.4× 7 0.6× 5 0.5× 58 5.8× 10 160
Vanessa Cui Lian Chong Singapore 4 14 0.6× 79 4.2× 24 2.0× 4 0.4× 32 3.2× 5 111
Lulu Wang China 7 11 0.5× 35 1.8× 5 0.4× 2 0.2× 15 1.5× 15 105
Susana Camara United Kingdom 5 14 0.6× 25 1.3× 13 1.1× 1 0.1× 12 1.2× 7 61
Haley Gula United States 6 6 0.3× 38 2.0× 9 0.8× 2 0.2× 6 0.6× 12 106
Afsaneh Ghasemzadeh Iran 5 9 0.4× 45 2.4× 6 0.5× 2 0.2× 11 1.1× 19 83
Chenyao Lin China 4 17 0.8× 94 4.9× 7 0.6× 2 0.2× 16 1.6× 8 145
Alon Schneider Hait Denmark 5 5 0.2× 42 2.2× 11 0.9× 3 0.3× 33 3.3× 5 86
Pascal Irrgang Germany 5 12 0.5× 49 2.6× 4 0.3× 3 0.3× 15 1.5× 9 87
Jerry Cade United States 3 9 0.4× 48 2.5× 5 0.4× 6 0.5× 58 5.8× 5 108

Countries citing papers authored by Graham T. Wehmeyer

Since Specialization
Citations

This map shows the geographic impact of Graham T. Wehmeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graham T. Wehmeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graham T. Wehmeyer more than expected).

Fields of papers citing papers by Graham T. Wehmeyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graham T. Wehmeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graham T. Wehmeyer. The network helps show where Graham T. Wehmeyer may publish in the future.

Co-authorship network of co-authors of Graham T. Wehmeyer

This figure shows the co-authorship network connecting the top 25 collaborators of Graham T. Wehmeyer. A scholar is included among the top collaborators of Graham T. Wehmeyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graham T. Wehmeyer. Graham T. Wehmeyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Qualls, David, Michael J. Buege, Phuong Dao, et al.. (2022). Tafasitamab and Lenalidomide in Relapsed/Refractory Large B Cell Lymphoma (R/R LBCL): Real World Outcomes in a Multicenter Retrospective Study. Blood. 140(Supplement 1). 787–789. 16 indexed citations
2.
Wehmeyer, Graham T., Eric A. Hoffman, Veerawat Phongtankuel, et al.. (2022). Choices and Outcomes of the Oldest Old Admitted During the First Wave of COVID-19 in New York City. Journal of Palliative Care. 37(3). 298–309. 2 indexed citations
3.
Alshak, Mark N., Han A. Li, & Graham T. Wehmeyer. (2021). Medical Students as Essential Frontline Researchers During the COVID-19 Pandemic. Academic Medicine. 96(7). 964–966. 7 indexed citations
4.
Kingery, Justin R., Paul Martin, Laura C. Pinheiro, et al.. (2021). Thirty-Day Post-Discharge Outcomes Following COVID-19 Infection. Journal of General Internal Medicine. 36(8). 2378–2385. 13 indexed citations
5.
Choi, Justin J., Lars F. Westblade, Han A. Li, et al.. (2021). Impact of a Multiplex Polymerase Chain Reaction Panel on Duration of Empiric Antibiotic Therapy in Suspected Bacterial Meningitis. Open Forum Infectious Diseases. 8(10). ofab467–ofab467. 11 indexed citations
6.
Sholle, Evan, Mangala Rajan, Mark N. Alshak, et al.. (2021). Comparing automated vs. manual data collection for COVID-specific medications from electronic health records. International Journal of Medical Informatics. 157. 104622–104622. 15 indexed citations
7.
Wehmeyer, Graham T., et al.. (2016). 1.65 Å resolution structure of the AraC-family transcriptional activator ToxT fromVibrio cholerae. Acta Crystallographica Section F Structural Biology Communications. 72(9). 726–731. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026